Andarix Pharmaceuticals Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond. | OncoHost OncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies. | ||
Founding Date | Founding Date 2018 | Founding Date N/A | Founding Date 2017 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Geneva, CH HQ | Locations HQ | Locations Binyamina-Giv'at Ada, IL HQ |
Employees | Employees 7 | Employees N/A | Employees 562% decrease |
Funding | |||
Latest funding round | Latest funding round $ 1.6m (over 3 years ago) | Latest funding round N/A | Latest funding round $ 35m (about 4 years ago) |
Total funding raised | Total funding raised $ 1.6m | Total funding raised N/A | Total funding raised $ 43m |
Andarix Pharmaceuticals is a company developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond.
View companyOncoHost is a clinical-stage precision oncology company that develops a host response profiling platform (PROphetTM) for cancer therapies.
View company